StonvexLoading…
StonvexStonvexStonvexCore line items from KYNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.44M | $29.62M | $46.80M | $140.73M |
Operating Income | $-45.90M | $-150.42M | $-322.72M | $-301.02M |
Net Income | $183.45M | $-47.58M | $-284.23M | $-293.65M |
EPS (Diluted) | $45.37 | $-11.89 | $-2.92 | $-3.14 |
Total Assets | $119.59M | $214.53M | $423.53M | $610.09M |
Total Liabilities | $115.12M | $398.16M | $585.73M | $611.57M |
Cash & Equivalents | $47.87M | $50.48M | $81.55M | $155.70M |
Free Cash Flow OCF − CapEx | $-4.81M | $-138.26M | $-317.54M | $-149.67M |
Shares Outstanding | 4.05M | 4.04M | 98.77M | 94.17M |